Alterna, a marketer of personal care products and therapeutic over-the-counter medicines, has signed a new trademark and know-how license agreement with Spirig Pharma AG of Egerkingen, Switzerland, which expands Alterna's exclusive rights to distribute Kerasal one-step exfoliating moisturizing foot ointment to 80 countries outside of North America.
A drug made by Daiichi-Sankyo was safe and effective in maintaining reductions in blood pressure in older patients, according to a new study presented at the American Society of Hypertension’s 26th annual meeting in New York.
Church & Dwight in April launched the First Response Digital Ovulation Test, a new at-home ovulation test that can detect a woman’s personal luteinizing hormone surge — the hormonal indication of ovulation — based on her own individual hormone levels.
Mars Chocolate North America is moving into the healthy snack space. The company recently introduced GoodnessKnows snack squares — fruit and nut bars made without artificial ingredients, colors or flavors.
Aetrex Worldwide is bringing shoppers a one-of-a-kind shopping experience featuring the most advanced technology in the footwear industry with the opening of its first retail concept in Englewood, N.J. An invite-only grand opening celebration will be held June 2.
Telecommunications provider Verizon Wireless and pharmacy benefit manager Medco Health Solutions have unveiled a mobile application that the companies said would allow patients and their doctors to instantly find the lowest-cost prescription drugs to meet their health needs and identify potentially harmful drug interactions.
Unilever's Dove celebrated the launch of its new Dove VisibleCare body wash collection with a contest that gave one woman the opportunity to get a taste of what celebrities experience on ABC's "Dancing with the Stars."
Pharmacy benefit manager Medco’s research arm is teaming up with personalized medicine and pharmacogenetics company AssureRx Health in a pilot program to evaluate adherence and medical care utilization among patients taking antidepressants and antipsychotics.
The Food and Drug Administration will expedite its review of an investigational drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the gastrointestinal tract, the company said Tuesday.
Drug maker Merck announced that it has kicked off an initiative that includes a wide range of public education and patient support programs, as well as research efforts to help improve care for people living with chronic hepatitis C virus infections.